Beximco Pharma building a global legacy from Bangladesh

Over the years, Bangladesh has witnessed remarkable progress in its healthcare sector. Maternal and child mortality rates have declined, life expectancy has increased, and immunization coverage has reached impressive levels. These achievements reflect not only policy commitment but also the relentless efforts of healthcare providers, pharmaceutical manufacturers, and millions of professionals who serve the nation every day.

As someone deeply involved in this journey through my role at Beximco Pharmaceuticals, I have seen how the country's pharmaceutical sector has evolved. Despite economic and infrastructural challenges, the industry has grown into one of Bangladesh's most promising sectors, both domestically and globally. Rising income levels, improved access to healthcare, better diagnostic capabilities, and a growing awareness about preventive health are all contributing to this transformation.

At Beximco Pharma, we have always believed that quality is the foundation of trust. Since our inception, we have made quality and compliance the core of everything we do. We have invested significantly in building modern, state-of-the-art manufacturing facilities benchmarked to the highest international standards. Equally important, we continue to invest in our people, nurturing a culture of learning, innovation, and accountability.

We understand that patients depend on us at some of the most critical moments of their lives. That responsibility drives us to go beyond commercial success. It's about earning trust, one prescription, one patient, one product at a time. Our unwavering commitment to delivering world-class yet affordable medicines has shaped who we are today, and it will continue to guide us as we move forward.

Standing out in a competitive market

Like I mentioned, Bangladesh's pharmaceutical market has grown rapidly, and with it, competition has become intense. In such an environment, differentiation is everything. From early on, Beximco Pharma took the pioneering route, focusing on specialised and technologically advanced formulations.

We are proud to be the country's largest producer and exporter of high-tech products, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), and sterile ophthalmics. These are not easy products to make, they require precision, deep technical know-how, and significant investment in R&D and quality systems.

Our dedicated and highly skilled team of scientists continuously works to refine formulations, enhance bioavailability, and develop difficult-to-copy delivery systems. This constant pursuit of innovation gives us a strong competitive edge and ensures that our medicines are not only effective but also aligned with global therapeutic advancements.

We don't just develop products, we develop solutions that improve lives. And this spirit of innovation runs through every department at Beximco Pharma, from formulation design to production, packaging, and global distribution.

Building consumer trust in supplements

One of the emerging areas in healthcare is nutritional and preventive wellness. However, supplements often face skepticism from consumers and rightly so, as the market is often flooded with products that lack scientific validation.

At Beximco Pharma, we approach this category differently. As a science-driven company, we focus on evidence-based products that meet rigorous quality and safety standards. Our supplements are trusted and widely prescribed by healthcare professionals across Bangladesh.

Brands such as Bextrum Gold, D Rise, Neurocare, Aristovit B/M, and Calorate have become household names, not just because of effective marketing, but because people have experienced real benefits from them. We believe consumer trust is earned through consistency, transparency, and results and we take that trust seriously.

Upholding international standards

When we first set out to export medicines beyond Bangladesh, our vision was simple yet ambitious: to prove that a Bangladeshi company could meet and even exceed global pharmaceutical standards. Today, Beximco Pharma's products reach patients in over 50 countries, including some of the most tightly regulated markets such as the United States, the European Union, and Australia.

We were the first Bangladeshi company to export medicines to the USA, a milestone that stands as a symbol of the country's capability in high-quality pharmaceutical manufacturing. The US remains our largest export destination today. This achievement did not happen overnight, it took years of rigorous preparation, facility upgrades, regulatory approvals, and above all, belief in our people.

To maintain our reputation for excellence, we continue to invest heavily in quality assurance, regulatory compliance, and infrastructure. Our facilities are routinely audited by global regulatory bodies, and our teams undergo regular training to stay ahead of evolving standards.

These efforts have earned Beximco Pharma numerous accolades, from the National Export Trophy (Gold), which we have won a record nine times, to prestigious international recognitions such as the CPhI Award, Scrip Awards, and the Global Generics & Biosimilars Award. But awards aside, what matters most to us is the confidence our global partners and patients place in our brand.

Biosimilars and oncology

Looking toward the future, we are focusing on high-value, high-impact areas, particularly biosimilars and oncology. These therapeutic areas represent the next frontier of modern medicine, where innovation and affordability must go hand in hand.

We have already partnered with several of the world's leading biotechnology companies to introduce US FDA and EU-approved biosimilar products in Bangladesh. This collaboration ensures that patients here can access cutting-edge treatments — such as biologics for cancer, autoimmune disorders, and chronic diseases — at a fraction of international costs.

The initial response from physicians and patients to our biosimilar portfolio has been overwhelmingly positive, reinforcing our belief that Bangladesh can and should be a hub for advanced pharmaceutical innovation.

Beyond biosimilars, we are also scaling up our capabilities in Active Pharmaceutical Ingredients (APIs) to strengthen our self-reliance and global competitiveness. This dual focus on formulation and API will help us expand our footprint across both developed and emerging markets.

A commitment beyond business

At the heart of Beximco Pharma's philosophy lies a deep sense of purpose, a belief that access to quality healthcare is a right, not a privilege. Every product we create, every market we enter, and every partnership we form is driven by that principle.

As I reflect on our journey, I see a company that has grown not just in size, but in impact. From being a local manufacturer to becoming a trusted global name, Beximco Pharma has consistently demonstrated that excellence, when combined with integrity and vision, can transform industries and lives alike.

Our mission remains clear: to deliver world-class, affordable, and reliable medicines to patients everywhere, and in doing so, to help build a healthier, more hopeful Bangladesh.